Coronary Stent Denied by Insurance? How to Appeal a PCI Denial

Percutaneous coronary intervention (PCI) — placing a stent in a narrowed coronary artery — is one of the most commonly performed cardiac procedures in the United States. For patients with significant coronary artery disease, it can relieve symptoms and, in acute settings, save lives. Yet denials for coronary stent placement are more common than most patients realize, particularly for elective or semi-elective procedures. Here's how to fight back.

Why Coronary Stent Claims Get Denied

Fractional flow reserve (FFR) not performed. FFR is a pressure-wire measurement taken during catheterization to assess the hemodynamic significance of a coronary stenosis. A stenosis that appears 60–70% on angiography may or may not be causing ischemia — and FFR objectively determines this. Many insurers now require FFR measurement before approving stenting for intermediate lesions (40–70% stenosis). If FFR was not measured and stenting was performed based on visual angiographic assessment alone, the insurer may deny the claim arguing the procedure wasn't proven necessary.

Medical management argument for stable disease. For patients with stable coronary artery disease and stable symptoms, the COURAGE trial (2007) and ISCHEMIA trial (2019) both showed that PCI does not reduce the risk of myocardial infarction or death compared to optimal medical therapy (OMT) alone in many stable patients. Insurers cite these trials to deny elective PCI, arguing OMT should be maximized first.

Elective vs. urgent/emergent classification disputes. Insurance companies sometimes dispute whether a stent was placed urgently (for ACS — STEMI, NSTEMI, unstable angina) or electively (stable angina). Urgent PCI for STEMI should never be denied. But if the stent was placed for an acute presentation that the insurer subsequently reclassifies as "stable," they may retroactively deny the claim.

Drug-eluting stent (DES) vs. bare-metal stent (BMS) cost disputes. Most patients today receive drug-eluting stents (DES), which reduce restenosis rates. Some older or restricted insurance plans may only cover bare-metal stents, or dispute the medical necessity of a specific DES type chosen.

Number of stents or vessels disputed. For multi-vessel coronary disease, insurers may approve one vessel intervention but deny coverage for simultaneous multi-vessel PCI, arguing that staged procedures are preferred. Documentation of the clinical rationale for treating multiple vessels in a single session is important.

Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization for elective procedures. Elective stent placement requires pre-authorization. If this wasn't obtained, or if the authorization was for diagnostic catheterization only but PCI was performed during the same session, the insurer may deny the PCI claim.

What Clinical Evidence and Guidelines Support

The ACC/AHA guidelines on stable ischemic heart disease and on revascularization articulate specific appropriate use criteria for PCI. Stenting is clearly appropriate for:

• STEMI (emergency)
• NSTEMI / unstable angina (urgent)
• High-risk stress test findings despite medical therapy
• Unacceptable symptoms despite maximal medical management
• Hemodynamically significant lesions confirmed by FFR (<0.80)
• Left main disease or proximal LAD disease in appropriate patients

If your case falls into any of these categories, it can be argued with clinical guidelines and literature.

Building Your Appeal

Include the full catheterization report and angiography findings. The interventional cardiologist's report should document the percent stenosis, the vessel affected, the clinical indication for intervention, and the lesion characteristics. Quantitative coronary analysis (QCA) data is useful.

Document FFR results if performed. If FFR was measured, include the report. An FFR value below 0.80 is strong evidence supporting PCI. If FFR was not performed, your cardiologist's letter should explain why visual assessment was sufficient — for example, a critical stenosis (>90%) or STEMI presentation where FFR is not indicated.

Address the medical management argument directly. If the insurer cites COURAGE or ISCHEMIA, have your cardiologist explain why your situation differs: symptom burden despite maximal medical therapy, the specific lesion anatomy, left main or proximal LAD involvement, or a high-risk stress test.

Cite ACC/AHA appropriate use criteria. Identify the specific clinical scenario that matches your case and confirm it is classified as "appropriate" in the ACC/AHA appropriate use criteria document.

For acute presentations, document the timeline. Include ER records, ECGs, troponin values, and the decision-making process that led to urgent catheterization and PCI.

After an Internal Denial

Request external independent review by a board-certified interventional cardiologist. External reviewers are far less likely to uphold denials for stent placement that met ACC/AHA appropriate use criteria.

Fight Back With ClaimBack

A coronary stent denial is serious — and reversible. ClaimBack helps you build the clinical and evidentiary case your insurer needs to reverse their decision.

Start your appeal at ClaimBack

Related Reading

• What Is Medical Necessity?
• Internal vs. External Insurance Appeal: What's the Difference?
• How to Write an Insurance Appeal Letter